Mylan Breaks Out On Buyout Rumors, New Hire, New Drugs - (Investor's Business Daily via NewsPoints Desk)

  • Shares in Mylan jumped as much as 7 percent on speculation that the company could be purchased by Teva, Investor's Business Daily reported Thursday.
  • The drugmaker also received a boost from the launch of new treatments to treat pain and opioid dependence and manage sobriety in patients with chronic alcoholism.
  • Mylan recently announced that fourth-quarter earnings per share and revenue climbed by 35 percent and 15 percent, respectively.
  • Meanwhile, analysts expect sales growth of 16 percent for 2015 and 13 percent for next year.

To read more NewsPoints articles, click here.

Reference Articles